Daily non-political popular news in brief.
Radiation preferred over surgery for patients with some stages of lung cancer
03-20-2007 · EurekAlert!After an initial chemotherapy treatment, radiation may be a better choice than surgery for patients with stage IIIA non-small-cell lung cancer, according to a randomized controlled trial published in the March 21 Journal of the National Cancer Institute. The authors suggest that a combination of chemotherapy and radiation should be the preferred treatment option for these patients.
Read more »
Keywords: radiation, preferred, surgery, patients, stages, lung, cancer, patient, stage
« Previous | Next »
Similar news on "Radiation preferred over surgery for patients with some stages of lung cancer":
- Radiation after surgery doubles survival time for some lung cancer patients
11-06-2006 · EurekAlert!
Patients with lung cancer that has spread to mediastinal lymph nodes -- located between the chest, breastbone and spine -- who receive radiation after surgery and chemotherapy live twice as long as patients who do not receive radiation after surgery, according to a study presented at the plenary session November 6, 2006, at the American Society for Therapeutic Radiology and Oncology's 48th Annual Meeting in Philadelphia.
Similar news · Read more »
- Report calls for using heated chemotherapy after colon cancer surgery to optimize patient survival
11-03-2006 · EurekAlert!
There is new hope for some of the most seriously ill colon cancer patients today, following the release of a consensus statement by 72 leading oncology surgeons from 14 countries, including the United States. The Peritoneal Surface Malignancy Group (PSMG) has concluded that surgery, followed by heated chemotherapy delivered through the lower abdomen of the patient before leaving the operating room, may significantly increase the life expectancy for patients with Stage IV colorectal cancer.
Similar news · Read more »
- Successful lung cancer surgery not enough to break nicotine dependence in many smokers
12-11-2006 · EurekAlert!
A new study has found that close to half of 154 smokers who had surgery to remove early stage lung cancer picked up a cigarette again within 12 months of their potentially curative operation, and more than one-third were smoking at the one year mark. Sixty percent of patients who started smoking again did so within two months of surgery.
Similar news · Read more »
- Study reveals differences in cancer stage presentation between rural and urban patients
11-09-2007 · EurekAlert!
New research published in the November issue of the Journal of the American College of Surgeons shows that urban colorectal and lung cancer patients present at later stages of disease than rural patients do. This finding is contrary to the common assumption that rural patients with cancer present at a later stage of disease in comparison with urban patients.
Similar news · Read more »
- Extra radiation dose prevents breast cancer return in young women
10-29-2007 · EurekAlert!
Women 40 years and younger with early-stage breast cancer who receive an additional high dose of radiation after undergoing breast-conserving surgery and standard radiation treatment are almost twice as likely to be free of cancer 10 years after treatment compared to those who don't receive the boost dose.
Similar news · Read more »
- Simple diagnostic test detects genetic signs of lung cancer in a patient's sputum
01-18-2007 · EurekAlert!
DNA coughed up along with phlegm could point to lung cancer, say researchers at the University of Maryland School of Medicine who are developing an inexpensive and non-invasive gene probe to help diagnose early stage lung cancer in current and former smokers.
Similar news · Read more »
- Adding radiation decreases breast cancer recurrence
01-22-2007 · EurekAlert!
Radiotherapy after breast conserving surgery for breast cancer reduces recurrence and prevents development of additional breast tumors in older women with early stage breast disease, according to a new study.
Similar news · Read more »
- Modeling lung cancer
02-12-2007 · EurekAlert!
In a new report in the February 15 issue of G&D, Dr. Martin McMahon and colleagues present a novel mouse model of non-small cell lung cancer, which will serve as a useful tool to test the efficacy of novel chemotherapeutic drug therapies in the early stages of lung tumorigenesis. Their paper provides evidence to support the use of a relatively new class of drugs, called MEK inhibitors, for lung cancer patients whose tumors contain mutations in the BRaf gene.
Similar news · Read more »
- Minimally invasive lung cancer surgery can improve chemotherapy outcomes
04-09-2007 · EurekAlert!
Patients who undergo a minimally invasive lung cancer surgery called thoracoscopic lobectomy may derive more benefit from the chemotherapy that follows, according to Duke University Medical Center researchers. These patients also have shorter hospital stays and accelerated recovery time compared with patients who have their tumors removed using the traditional surgical approach that involves opening the chest.
Similar news · Read more »
- Targeted, oral agent Enzastaurin shows favorable results
06-02-2007 · EurekAlert!
Enzastaurin, an investigational targeted, oral agent under development by Eli Lilly and Company, showed encouraging results in treating patients with late-stage non-small cell lung cancer (NSCLC), according to data presented today at the 43rd Annual Meeting of the American Society of Clinical Oncology (ASCO).
Similar news · Read more »
